john p. leonard, md, on the fda approval of tazemetostat for follicular lymphoma
Published 3 years ago • 190 plays • Length 8:58Download video MP4
Download video MP3
Similar videos
-
1:16
dr. leonard on the fda approval of tazemetostat in follicular lymphoma
-
3:55
accelerated approval of tazemetostat for follicular lymphoma
-
1:06
dr. john leonard on treatment options in follicular lymphoma
-
1:07
dr. john leonard on when to treat patients with follicular lymphoma
-
6:04
tribute to john p. leonard, md at the 2018 annual gala
-
1:01
john p. leonard, md, discusses novel agents for treating aggressive lymphomas
-
1:40
john p. leonard, md, on the role checkpoint inhibitors play in lymphoma treatment algorithms
-
2:01
lymphoma treatments - dr. john leonard
-
1:33
dr. john leonard on treatment options for relapsed follicular lymphoma
-
0:51
john p. leonard, md discusses improving outcomes in high risk follicular lymphoma patients
-
1:04
dr. leonard on treating relapsed patients with follicular lymphoma
-
1:37
dr. leonard on ibrutinib combined with chemotherapy in follicular lymphoma
-
1:56
john leonard, m.d.
-
0:38
tazemetostat and rituximab in r/r follicular lymphoma
-
6:17
novel therapies for the treatment of follicular lymphoma
-
1:04
john p. leonard, md discusses lenalidomide plus rituximab for the treatment of mcl
-
1:31
dr. leonard on lenalidomide with rituximab in follicular lymphoma
-
5:52
r2-chop for relapsed follicular lymphoma
-
7:25
evolving treatment landscape of follicular lymphoma